Top compounds associated with response to GRM4


Feature Type Standardized
Nominal ANOVA
mRNA SU11274 CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-08
mRNA manumycin A CTRPv2 pan-cancer AAC 0.17 3e-08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 4e-08
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC 0.39 5e-08
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 7e-08
mRNA BRD-K48477130 CTRPv2 pan-cancer AAC 0.3 1e-07
mRNA darinaparsin CTRPv2 pan-cancer AAC 0.25 3e-07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 3e-07
Download CSV